A genomic and epigenomic atlas of prostate cancer in Asian populations

Journal: Nature

Published: 2020-03-25

DOI: 10.1038/s41586-020-2135-x

Affiliations: 29

Authors: 55

Go to article
Institutions Share
Changhai Hospital, SMMU, China 0.47
Shanghai Key Laboratory of Cell Engineering, China 0.06
Department of Genetics, WUSTL, United States of America (USA) 0.04
Edison Family Center for Genome Sciences and Systems Biology (CGS), WUSTL, United States of America (USA) 0.04
Beijing Novogene Bioinformation Technology Co., Ltd., China 0.04
First Affiliated Hospital, ZZU, China 0.04
Xuzhou Central Hospital (XZCH), China 0.02
Huadong Hospital Affiliated to Fudan University, China 0.02
Affiliated Hospital of Hebei University, HBU, China 0.02
Shishi (Overseas Chinese) Hospital, China 0.02
Shaoxing Central Hospital, China 0.02
Institute of Urology at LuoHu Affiliated Hospital, SZU, China 0.02
Zhejiang Provincial People's Hospital, China 0.02
Pudong Gongli Hospital, China 0.02
Zhongda Hospital, SEU, China 0.02
Second Military Medical University (SMMU), China 0.02
The First Affiliated Hospital of Soochow University, China 0.02
First Affiliated Hospital, AHMU, China 0.02
Research Institute of Surgery, Daping Hospital, China 0.02
First Affiliated Hospital, ZJU, China 0.02
Shanghai Changzheng Hospital, SMMU, China 0.02
Tongji Hospital (TJH), HUST, China 0.02
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China 0.01
State Key Laboratory of Reproductive Medicine (SKLRM), NJMU, China 0.01
Institute of Translational Medicine (ITM), SMMU, China 0.01
University of Chinese Academy of Sciences (UCAS), Shanghai, China 0.01
CAS Key Laboratory of Tissue Microenvironment and Tumor, SIBS CAS, China 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER